彩鲫ran基因原核表达蛋白多克隆抗体的制备

采用SDS-PAGE分离纯化彩鲫(Carassius auratus gibelio)ran基因编码区cDNA全长序列的原核表达蛋白,并以此为抗原免疫家兔,制备了相应的多克隆抗体;W estern b lotting结果表明,该抗体效价为1∶1000,具有较高的特异性。并从抗原蛋白相对分子质量、每次注射蛋白量、注射方式、注射途径等诸方面对该技术的要点进行了介绍。     

黄鳍鲷骨骼肌伴肌动蛋白的纯化及其抗体制备

采用Sephacryl S-400凝胶过滤柱层析和电洗脱等纯化方法,首次从黄鳍鲷骨骼肌中分离纯化到伴肌动蛋白,并制备了特异性多克隆抗体.多克隆抗体经Protein A-Sepharose亲和层析柱纯化得到高纯度免疫球蛋白G(IgG).采用聚丙烯酰胺凝胶电泳(SDS-PAGE)、免疫斑点印迹(Dot-Blot)和免疫印迹(Western-Blot)等方法对纯化的伴肌动蛋白及其多克隆抗体进行分析鉴定,并研究了不同贮藏条件下伴肌动蛋白的变化情况.SDS-PAGE结果显示本研究从黄鳍鲷骨骼肌中分离纯化了高纯度伴肌动蛋白;Dot-Blot检测结果显示兔抗黄鳍鲷伴肌动蛋白多克隆抗体效价为5×104;Western-blot检测表明兔抗黄鳍鲷伴肌动蛋白多克隆抗体能与肌原纤维蛋白中的伴肌动蛋白发生特异性反应,而与其它蛋白不发生免疫交叉反应.     

草鱼呼肠孤病毒Ⅱ型VP6蛋白多克隆抗体制备及其特异性分析

为了制备高效的草鱼呼肠孤病毒Ⅱ型VP6蛋白多克隆抗体并对其特异性进行鉴定,实验以草鱼呼肠孤病毒Ⅱ型HZ08株为模板,采用PCR方法扩增S9基因,将该S9基因与p ET-32a(+)载体连接构建p ET-32a-S9原核表达载体,转化到大肠杆菌BL21(DE3)后用IPTG诱导表达;纯化后的重组VP6蛋白免疫新西兰兔,制备多克隆抗体,使用间接ELISA方法测定抗体效价,Western blot和IFA试验鉴定抗VP6蛋白多克隆抗体特异性。结果显示草鱼呼肠孤病毒Ⅱ型的S9基因在原核表达载体中能够正确地表达VP6蛋白,纯化的重组蛋白免疫新西兰兔制备的抗VP6多克隆抗体,经间接ELISA方法测定其效价约为1∶105,Western blot和IFA试验结果显示制备的多克隆抗体能特异性识别GCRVⅡ型毒株,而不能识别GCRV I型、Ⅲ型以及其它病毒,表明该多克隆抗体具有较高的特异性。研究表明制备的抗VP6蛋白多克隆抗体能够特异性识别GCRVⅡ型病毒,为GCRVⅡ型病原学研究及草鱼出血病临床诊断奠定基础。     

抑制素α基因诱导表达及其多克隆抗体的制备

目的为获得诱导表达的绵羊卵泡抑制素基因蛋白及其多克隆抗体。方法试验首先对绵羊卵泡抑制素α基因原核表达产物进行诱导表达及可溶性分析,其次运用以镍柱亲层析和尿素透析的方法收集其表达蛋白并用弗氏佐剂对其进行乳化,最后将乳化后的蛋白免疫制剂对新疆双峰骆驼进行多次加强免疫,以获得卵泡抑制素α基因多克隆抗体。结果绵羊卵泡抑制素α基因原核表达产物在IPTG诱导作用下呈包涵体形式存在,蛋白纯度较高,免疫后血清抗体效价为5.12×10~6,SDS-PAGE电泳分析结果显示,在39 ku有常规抗体的条带存在,在26 ku处存在纳米抗体的条带。结论绵羊卵泡抑制素α蛋白经纯化后对双峰骆驼免疫可以获得高效价、高纯度的抑制素α多克隆抗体。     

黄鳝血清转铁蛋白多克隆抗体的制备及检测

为实现黄鳝血清转铁蛋白基因的原核表达并制备其多克隆抗体,利用基因特异性引物从黄鳝肝脏cDNA中扩增黄鳝转铁蛋白的C端序列,亚克隆至原核表达载体pET-28a(+)中,构建pET/Tf-C重组表达载体;转化大肠杆菌BL21(DE3)后进行IPTG诱导。利用Ni离子亲和层析技术纯化Tf-C蛋白,并免疫新西兰兔制备多克隆抗体;通过间接ELISA技术和组织蛋白印迹对制备的多克隆抗体进行检测。试验结果表明,成功构建pET/Tf-C原核表达载体,并实现了蛋白的表达和纯化;制备的多克隆抗体效价大于1∶25 600,并能特异性地识别来源于黄鳝不同组织的血清转铁蛋白。研究结果对黄鳝血清转铁蛋白功能的研究奠定了基础。     

牙鲆血清免疫球蛋白的分离纯化及部分特性分析

运用Sephacryl S-200凝胶层析和HiTrap rProtein ASepharose亲和层析2种方法对牙鲆(Paralichthys olivaceus)血清免疫球蛋白进行分离纯化,结果表明,牙鲆免疫球蛋白分布于33%~50%的硫酸铵饱和溶液中,其中45%的分离效果最好。凝胶层析和亲和层析样品均出现2个蛋白峰,用还原SDS-PAGE检测确定牙鲆免疫球蛋白存在于第2个蛋白峰中。牙鲆免疫球蛋白重链分子量约为75.4 kD,轻链分子量约为29.9 kD和28.2 kD,推测牙鲆血清免疫球蛋白的分子量为836 kD。制备了兔抗牙鲆免疫球蛋白多克隆抗体,免疫双扩散法检测多克隆抗体效价为1∶32,免疫斑点法检测多克隆抗体效价至少为1∶1 600。运用免疫印迹法(Western-bloting)检测了兔抗牙鲆免疫球蛋白多克隆抗体的特异性,实验证明该抗体与牙鲆全血清中免疫球蛋白重链、轻链反应均成阳性。     

创伤弧菌外膜蛋白多克隆抗体的制备及其特性分析

[目的]制备创伤弧菌特异性抗体,为建立免疫学快速检测创伤弧菌提供参考依据。[方法]以创伤弧菌外膜蛋白作为抗原,将抗原分多次免疫新西兰大白兔获得特异性多克隆抗体,采用蛋白G亲和层析法纯化多克隆抗体,通过间接ELISA和Western Blot测定创伤弧菌外膜蛋白多克隆抗体的效价、敏感性和特异性。[结果]实验获得了纯度较高的创伤弧菌外膜蛋白多克隆抗体,效价为1∶64 000;抗体对创伤弧菌具有高的特异性,它与多株致病菌均无明显交叉反应,其对创伤弧菌检测灵敏度为103CFU/m L;Western Blot分析表明,制备的多克隆抗体能识别创伤弧菌外膜蛋白,创伤弧菌外膜蛋白具较强的抗原性。[结论]创伤弧菌外膜蛋白多克隆抗体具有较高特异性和灵敏性,可应用于创伤弧菌的快速、灵敏的免疫学检测。     

鲤春病毒血症病毒核蛋白、磷蛋白与基质蛋白的表达、抗体制备及免疫原性比较

鲤春病毒血症病毒(SVCV)能够引起鲤科鱼类大量死亡,被世界动物卫生组织(OIE)列为必须申报的重要疫病,也是我国唯一被列为一类疫病的鱼类传染病。为建立SVCV的快速免疫学诊断方法,研究其主要结构蛋白间的免疫原性差异,实验首先采用原核表达系统克隆并诱导表达,纯化SVCV的核蛋白(N)、磷蛋白(P)和基质蛋白(M),并进一步免疫新西兰白兔制备抗血清,抗血清经Protein A柱进一步纯化获得3种蛋白的多克隆抗体。利用间接酶联免疫吸附测定(ELISA)和免疫印迹实验(Western blot)对抗体效价和特异性进行分析验证。结果发现,SVCV的N、P和M重组蛋白均在原核表达系统获得大量表达,且表达的蛋白经纯化后免疫实验动物产生了相应的多克隆抗体。Western blot结果显示,3种蛋白抗体均与SVCV重组蛋白及天然蛋白发生特异性的免疫反应。ELISA结果显示,针对P蛋白制备的抗体效价最高,可达409 600;针对N和M蛋白制备的抗体效价也均大于204 800。同时,特异性检测实验结果显示,制备的3种蛋白抗体均仅与SVCV发生特异性免疫反应,而与SVCV宿主其他易感病毒均不发生交叉反应。实验结果将对SVCV的快速诊断及疫苗开发提供新的手段和思路。     

草鱼呼肠孤病毒HZ08株S10编码蛋白多克隆抗体制备及其特性分析

为研究草鱼呼肠孤病毒(GCRV)HZ08株S10基因节段编码蛋白的可能功能,采用PCR方法扩增草鱼呼肠孤病毒HZ08株S10基因节段,并把该基因节段克隆至表达载体pET-32a(+),获得的重组表达载体pET-32a-S10转化到大肠杆菌BL21(DE3)菌株,用IPTG诱导表达,表达产物通过SDS-PAGE分析鉴定后,再通过变性、过Ni柱纯化、透析复性纯化获得目的蛋白。然后用纯化的重组蛋白免疫昆明小白鼠,制得多克隆抗体,用间接ELISA方法测定抗体效价,用Western blot和IFA(间接免疫荧光试验)鉴定抗体特异性。结果表明,SDS-PAGE分析表达的重组蛋白约为53 ku,大小与预期相符,目的蛋白主要存在于包涵体中;过Ni柱纯化、透析复性纯化后的重组蛋白纯度可达97.4%;间接ELISA测得制备的多克隆抗体效价约为1∶106,Western blot和IFA结果显示,制备的多克隆抗体能识别HZ08毒株,表明S10编码蛋白为GCRV-HZ08株的结构蛋白。     

仿刺参补体AjC3部分基因的原核表达及多克隆抗体的制备

通过制备仿刺参补体C3(AjC3)多克隆抗体,为进一步研究仿刺参补体AjC3免疫机制奠定基础。利用PCR技术扩增AjC3部分基因片段(4556~5110bp),将该片段与原核表达载体pGS-21a连接。将重组表达质粒转化到Transetta(DE3)中经IPTG诱导表达。表达的重组蛋白经镍柱纯化后,作为抗原免疫小鼠制备AjC3多克隆抗体。分别用间接ELISA,Western blot检测抗体的效价和特异性。结果显示,PCR扩增得到约555bp的目的片段,重组蛋白分子量大小约56ku;间接ELISA检测抗体效价达1∶25600,Western blot结果显示,多克隆抗体具有良好的特异性。该试验成功的制备了补体AjC3多克隆抗体,为补体AjC3的进一步研究提供了检测工具。     

Antibody production in Japanese eels, Anguilla japonica Temminck & Schlegel

Adult Japanese eels, Anguilla japonica Temminck & Schlegel, (200–250 g, 45–55 cm) were immunized by intramuscular injection with goat IgG. After 5 weeks, eel immunoglobulin (Ig) was purified using affinity chromatography. The purified eel Ig was used to immunize rabbits to produce anti-eel Ig antibody. The highest antibody ELISA value in eels was reached 3 weeks after initial immunization with goat IgG, and then gradually decreased. The antibody could still be detected at 140 days post-immunization. The optimal temperature for antibody production was 30°C. Freund's complete adjuvant and secondary immunization both increased antibody production in eels.     

Induction,purification and partial characterization of vitellogenin in an Indian major carp Catla catla (Ham.)

Vitellogenin was purified from the serum of 17‐β estradiol (E₂)‐induced juvenile Catla catla using a simple two‐step purification procedure i.e. selective chemical precipitation followed by gel filtration chromatography. Purified protein migrated as single band in a native gradient PAGE which indicated the purity of the sample. The molecular weight of the native catla vitellogenin (~440 kDa) was determined using gel filtration chromatography. In SDS‐PAGE under reducing conditions catla vitellogenin dissociated into three major sub units at 115 kDa, 102 kDa and 73 kDa along with a few faint bands. Confirmation of purified protein as catla vitellogenin was supported by multiple physiological evidences, e.g. absence in male as well as juvenile sera and presence in matured female fish, ability to be synthesized upon estradiol injection in immature fish and certain unique biochemical properties like high molecular weight, phospholipoglycoprotein nature of the molecule. Western blot analysis showed that polyclonal antibody raised against purified protein detected vitellogenin in the sera of catla and in a few species selected from Cyprinidae family. These antisera were used to detect vitellogenin in liver tissue of hormone‐induced catla using immunohistochemistry and its applicability in other immunoassays is discussed.     

鲤肠道小肽转运载体PepT1多克隆抗体的制备及其组织表达分析

为从蛋白水平研究小肽转运载体(PepT1)在鲤(Cyprinus carpio L.)不同组织中的表达及分布规律,本研究采用PCR法获得PepT1 cDNA片段,并转化至大肠杆菌Rosetta,对目标多肽进行原核表达,将Pep T1重组蛋白纯化后免疫新西兰长耳兔(Oryctolagus cuniculus),获取兔抗鲤PepT1多克隆抗体。采用ELISA检测抗体效价,免疫组化检测PepT1的组织表达情况,并用荧光实时定量PCR技术检测PepT1转录水平组织表达情况。结果显示,目标多肽分子量约为28 kD;抗体效价达到4×10~5。PepT1在鲤的前肠、中肠、后肠、脾、肝胰脏和肾中均有表达。肠道组织PepT1的高表达与其主要完成食物中肽的吸收功能密切相关,且吸收部位主要集中在前肠和中肠;肾中PepT1免疫染色阳性区域也较为明显,这与肾小管基底膜存在对短肽的重吸收功能相关。此外,肝胰脏和脾PepT1也有一定量的表达,可能与这两个重要器官代谢旺盛有关。本研究制备的兔抗鲤PepT1多克隆抗体能够有效识别鲤各组织中的PepT1蛋白,在后续研究中亦可用于其他鱼类PepT1转运蛋白的表达定位和定量研究。     

Cloning,expression of Vibrio alginolyticus outer membrane protein‐OmpU gene and its potential application as vaccine in crimson snapper,Lutjanus erythropterus Bloch

The outer membrane proteins of the marine aquatic animal pathogen, Vibrio alginolyticus, play an important role in the virulence of the bacterium and are potential candidates for vaccine development. In this study, the gene encoding an outer membrane protein‐OmpU was cloned and expressed in Escherichia coli. Polyclonal antibodies were raised in rabbits against the purified recombinant OmpU, and the reaction of the antibody was confirmed by Western blotting using the isolated OmpU and the recombinant OmpU of V. alginolyticus. To analyze the immunogenicity of the recombinant OmpU, crimson snapper, Lutjanus erythropterus Bloch, were immunized by intraperitoneal injection, and antibody response was assessed by the enzyme‐linked immunosorbent assay (ELISA). The results demonstrated that the recombinant OmpU produced an observable antibody response in all sera of the vaccinated fish. The vaccinated fish were challenged by virulent V. alginolyticus and observed to have high resistance to infection. These results indicate that the recombinant OmpU is an effective vaccine candidate against V. alginolyticus in L. erythropterus.     

建鲤组织蛋白酶L 的原核表达、纯化鉴定及多克隆抗体的制备

对原核表达的重组建鲤组织蛋白酶L(Cathepsin L,CAT L)蛋白进行尿素洗涤和Ni-NTA亲和层析纯化,该目的蛋白经300 mmol/L咪唑洗脱为单一峰,SDS-PAGE结合TSK-GEL G2000SWxl凝胶过滤高效液相色谱分析表明重组CAT L获得了高度纯化,分子量约28 k D,纯度超过95%。Z-Phe-Arg-MCA底物测活法显示该重组CAT L表现为半胱氨酸蛋白酶活性,能与其内源抑制因子Cystatin以1︰1的摩尔比结合,具有生物学活性。以纯化的重组CAT L蛋白免疫Balb/C小鼠获得抗血清,经ELISA法检测获得的CAT L抗血清效价高于1︰512000;Western blotting鉴定结果表明该抗体具有良好的特异性,能够识别原核表达的重组CAT L蛋白。免疫组织化学分析结果表明,该抗体还能识别建鲤小肠、肝胰脏、脾、背肌和心肌组织表达的内源性CAT L蛋白。因此可利用该抗体从蛋白水平检测CAT L在鱼类不同组织中的表达和分布情况。     

Immunological detection of translation products of type V/XI collagen α1 gene and their degradation products in red sea bream muscle

We previously cloned cDNA of type V/XI collagen α1 chain (ColVa1) gene from cultured cells derived from red sea bream embryo. We raised an antibody against the deduced C-telopeptide of ColVa1 in order to detect the translation products of this cDNA and their degradation products in red sea bream muscle. To improve its specificity, the antibody was purified from rabbit antiserum by use of an affinity column cross-linked with recombinant C-terminal peptide of ColVa1 produced by Epicurian coli. The purified antibody recognized a band corresponding to the α chain of type V/XI collagen in western blot analysis of the extract of cultured cells. The antibody also recognized two bands in acid-soluble and pepsin-solubilized collagens, indicating that the translation products of the ColVa1 gene are present in muscle and that bands correspond to α and β chains of type V/XI collagen. A band corresponding to a molecular weight of approximately 65 k was detected in the NaOH extracts of muscle, suggesting that type V/XI collagen α1 chain is restrictedly digested in red sea bream muscle.     

The in vitro inhibition of proteases from Cryptobia salmositica Katz by a monoclonal antibody (MAb-001) against a glycoprotein on the pathogenic haemoflagellate

The monoclonal antibody (MAb-001), which was produced against a surface membrane glycoprotein on C. salmositica , significantly inhibited the activities of the intracellular proteases of the parasite. The total activity in the partially purified metallo-protease, and about 80% of activity in the partially purified cysteine protease, were inhibited by the antibody (at 10 μg protein ml^–1). The inhibitory effects of the antibody on the proteases were also demonstrated using haemoglobin (substrate)-SDS-PAGE. The activities of the metallo-protease band (200 kDa) and the three cysteine protease bands (66, 70 and 97 kDa) were inhibited by MAb-001, but the activity of the fourth cysteine protease band (49 kDa) was not affected. Similar inhibitory effects of the antibody were also found in the crude protease extract (parasite lysate), except that more antibody was required to obtain the same level of inhibition. The metallo-protease band was more sensitive than the cysteine protease bands to the antibody.     

尼罗罗非鱼无乳链球菌Sip蛋白乳酸菌活载体口服疫苗的研制及其免疫效果

链球菌病是威胁我国罗非鱼养殖产业健康发展的重要病害之一。为研制出免疫效果好、操作简便的罗非鱼链球菌病疫苗,本研究构建重组表达无乳链球菌Sip蛋白的穿梭质粒pNZ8124-Sip,通过酶切和测序验证后电转化乳酸乳球菌NZ9000,获得能够诱导重组表达无乳链球菌Sip蛋白的乳酸菌活菌载体疫苗。采用SPS-PAGE电泳摸索最佳诱导浓度和诱导时间以获得最大表达量,通过镍柱纯化目的蛋白并进行Western blot检测;利用不同浓度的重组乳酸菌活载体疫苗灌胃口服免疫尼罗罗非鱼,采用间接ELISA法测定免疫后血清抗体水平变化,通过人工腹腔注射感染无乳链球菌获得相对免疫保护率。研究结果显示,构建的重组乳酸乳球菌可通过nisin诱导表达大小为48 ku特异性蛋白,与目的蛋白大小一致;PAGE电泳显示,重组蛋白主要以可溶蛋白和包涵体2种形式存在,其中胞内可溶性蛋白浓度达7.65 mg/mL;诱导表达的最佳条件为100 ng/mL nisin诱导6 h;Western blot检测结果显示,诱导蛋白可与鼠抗His标签抗体特异性结合。口服免疫结果显示,中浓度组(2.24×10~(10) CFU/mL)和低浓度组(2.24×10~9 CFU/mL)免疫2次能够显著提高尼罗罗非鱼的血清抗体水平和抗无乳链球菌感染能力,中浓度免疫组的相对免疫保护率最高为41.0%。本研究可为罗非鱼链球菌病口服疫苗的研究奠定基础,具有广阔的应用前景。